Concurrent radiochemotherapy in advanced hypopharyngeal cancer

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Krstevska, Valentina ^a   Stojkovski, Igor ^a   Lukarski, Dusko ^b  

^a SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

^b University Clinic of Radiotherapy and Oncology   (Macedonia)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; HYPOPHARYNX CANCER; LEUKOPENIA; MALE; MUCOSA INFLAMMATION; OVERALL SURVIVAL; RADIATION DOSE; RETROSPECTIVE STUDY; SUBCUTANEOUS TISSUE; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT REDUCTION; COMPUTER ASSISTED RADIOTHERAPY; HYPOPHARYNX TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77952268953     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-39     Document Type: Article

References (48)

1. Hoffman HT, Karnell LH, Funk GF, Robinson RA, Menck HR. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998, 124:951-962.
2. Johansen LV, Grau C, Overgaard J. Hypopharyngeal squamous cell carcinoma: treatment results in 138 consecutively admitted patients. Acta Oncol 2000, 39:529-536. 10.1080/028418600750013465, 11041117.
3. Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK, Gay EG, Langer CJ. National Cancer Database report on cancer of the head and neck: 10-Year update. Head Neck 2009, 31:748-758. 10.1002/hed.21022, 19189340.
4. Hung S-K, Chen H-L, Hsieh C-H, Hsu W-L, Chang K-H, Liu D-W, Chen Y-J, Lee M-S. Treatment of advanced hypopharyngeal cancer-comparison of two modalities. Tzu Chi Med J 2006, 18:15-21.
5. Ho CM, Ham KH, Wei WI, Yuen PW, Lam LK. Squamous cell carcinoma of the hypopharynx--analysis of treatment results. Head Neck 1993, 16:405-412.
6. Pingree TF, Davis RK, Reichman O, Derrick LM. Treatment of hypopharyngeal carcinoma: a 10-year review of 1,362 cases. Laryngoscope 1987, 97:901-904. 10.1288/00005537-198708000-00002, 3613786.
7. Lajtmam Z, Manestar D. A comparison of surgery and radiotherapy in the management of advanced pyriform fossa carcinoma. Clin Otolaryngol 2001, 26:59-61. 10.1046/j.1365-2273.2001.00430.x, 11298170.
8. Tai S-K, Yang M-H, Wang L-W, Tsai T-L, Chu P-Y, Wang Y-F, Huan J-L, Chang S-Y. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer. Jpn J Clin Oncol 2008, 38:521-527. 10.1093/jjco/hyn073, 18697758.
9. Arriagada R, Eschwege F, Cachin Y, Richard JM. The value of combining radiotherapy with surgery in the treatment of hypopharyngeal and laryngeal cancers. Cancer 1983, 51:1819-1825. 10.1002/1097-0142(19830515)51:10<1819::AID-CNCR2820511011>3.0.CO;2-G, 6831347.
10. Mirimanoff RO, Wang CC, Doppke KP. Combined surgery and postoperative radiation therapy for advanced laryngeal and hypopharyngeal carcinomas. Int JRadiat Oncol Biol Phys 1985, 11:499-504.
11. Sewnaik A, Hoorweg JJ, Knegt PP, Wieringa MH, Beek JMH, Kerrebijn JDF. Treatment of hypopharyngeal carcinoma: analysis of nationwide study in the Netherlands over a 10-year period. Clin Otolaryngol 2005, 30:52-57. 10.1111/j.1365-2273.2004.00913.x, 15748191.
12. Kim WT, Ki YK, Nam JH, Kim DW, Lee BJ, Wang SG, Kyuon BH. The results of postoperative radiotherapy for hypopharyngeal carcinoma. J Kor Soc Thera Radiol Onco 2004, 22:254-64.
13. Beauvillain C, Mahe M, Bourdin S, Peuvrel P, Bergerot P, Rivière A, Vignoud J, Deraucourt D, Wesoluch M. Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinomas. Laryngoscope 1997, 107:648-653. 10.1097/00005537-199705000-00017, 9149168.
14. Lefebvre JL, Rolland F, Tesselaar M, Bardet E, Leemans CR, Geoffrois L, Hupperets P, Barzan L, de Raucourt D, Chevalier D, Licitra L, Lunghi F, Stupp R, Lacombe D, Bogaerts J, Horiot JC, Bernier J, Vermorken JB. Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst 2009, 101:142-152. 10.1093/jnci/djn460, 2724854, 19176454.
15. Lefebvre J-L, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 1996, 88:890-899. 10.1093/jnci/88.13.890, 8656441.
16. Robson A. Evidence-based management of hypopharyngeal cancer. Clin Otolaryngol 2002, 27:413-420. 10.1046/j.1365-2273.2002.00274.x, 12383309.
17. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003, 349:2091-2098. 10.1056/NEJMoa031317, 14645636.
18. Adelstein DJ, Saxton JP, Rybicki LA, Esclamado RM, Wood BG, Strome M, Lavertu P, Lorenz RR, Carroll MA. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution. J Clin Oncol 2006, 24:1064-1071. 10.1200/JCO.2005.01.5867, 16505425.
19. Urba SG, Moon J, Giri PGS, Adelstein DJ, Hanna E, Yoo GH, LeBlanc M, Ensley JF, Schuller DE. Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a southwest oncology group trial. J Clin Oncol 2005, 23:88-95. 10.1200/JCO.2005.04.017, 15625363.
20. Wendt TG, Grabenbauer GG, Rodel CM, Thiel HJ, Aydin H, Rohloff R, Wus-trow TP, Iro H, Popella C, Schalhorn A. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 1998, 16:1318-1324.
21. Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, George SL, Huang AT, Prosnitz LR. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998, 338:1798-1804. 10.1056/NEJM199806183382503, 9632446.
22. Vokes EE, Stenson K, Rosen FR, Kies MS, Rademaker AW, Witt ME, Brockstein BE, List MA, Fung BB, Portugal L, Mittal BB, Pelzer H, Weichselbaum RR, Haraf DJ. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 2003, 21:320-326. 10.1200/JCO.2003.06.006, 12525525.
23. Jeremic B, Shibamoto Y, Milicic B, Nikolic N, Dagovic A, Aleksandrovic J, Vaskovic Z, Tadic L. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 2000, 18:1458-1464.
24. Corvo R. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiother Oncol 2007, 85:156-170. 10.1016/j.radonc.2007.04.002, 17482300.
25. Hall SF, Groome PA, Irish J, O'Sullivan B. Radiotherapy or Surgery for Head and Neck Squamous Cell Cancer. Establishing the Baseline for Hypopharyngeal Carcinoma?. Cancer 2009, 115:5711-5722. 10.1002/cncr.24635, 19708030.
26. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M. AJCC Cancer Staging Manual. 2002, 6:31-46. New York: Springer-Verlag.
27. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995, 31:1341-1346.
28. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981, 47:207-214. 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6, 7459811.
29. Kaplan EL, Meier P. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma. J Am Stat Assoc 1958, 53:457-81.
30. Yoon MS, Chung W-K, Ahn S-J, Nam T-K, Nah B-S, Song J-Y, Lim SC, Lee JK. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma. Acta Oto-Laryngol 2008, 128:590-596.
31. Lee NY, O'Meara W, Chan K, Della-Bianca C, Mechalakos JG, Zhung J, Wolden SL, Narayana A, Kraus D, Shah JP, Pfister DG. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys 2007, 69:459-468.
32. Elias MM, Hilgers FJM, Keus RB, Gregor RT, Hart AAM, Balm AJM. Carcinoma of the pyriform sinus: a retrospective analysis of treatment results over a 20-year period. Clin Otolaryngol 1995, 20:249-253. 10.1111/j.1365-2273.1995.tb01860.x, 7554339.
33. Kim S, Wu H-G, Heo D-S, Kim KH, Sung M-W, Park C. Advanced hypopharyngeal carcinoma treatment results according to treatment modalities. Head Neck 2001, 23:713-717. 10.1002/hed.1101, 11505479.
34. Gupta T, Chopra S, Agarwal JP, Laskar S-G, D'Cruz AK, Shrivastava SK, Dinshaw KA. Squamous cell carcinoma of the hypopharynx: Single-institution outcome analysis of a large cohort of patients treated with primary non-surgical approaches. Acta Oncol 2009, 48:541-548. 10.1080/02841860802488839, 18979267.
35. Cummings B, Keane T, Pintilie M, Warde P, Waldron J, Payne D, Liu F, Bissett R, MsLean M, Gullane P. Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer. Radiother Oncol 2007, 85:7-16. 10.1016/j.radonc.2007.09.010, 17920715.
36. Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, Garden AS, Ridge JA, Cooper JS, Ang KK. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinoma: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000, 48:7-16. 10.1016/S0360-3016(00)00663-5, 10924966.
37. Overgaard J, Hansen H, Specht L, Overgaard M, Grau C, Andersen E, Bentzen J, Bastholt L, Hansen O, Johansen J. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomized controlled trial. Lancet 2003, 363:933-940.
38. Skladowski K, Maciejewski J, Golen M, Pilecki B, Przeorek W, Tarnawski R. Randomized clinical trial of 7-day continuous accelerated irradiation (CAIR) of head and neck cancer: report on 3-year tumor control and normal tissue toxicity. Radiother Oncol 2000, 55:93-102. 10.1016/S0167-8140(00)00139-0, 10799719.
39. Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, Bernier J, Horiot J-C, Le Maitre A, Pajak TF, Poulsen MG, O'Sullivan B, Dobrowsky W, Hliniak A, Skladowski K, Hay JH, Pinto LHJ, Fallai C, Fu KK, Sylvester R, Pignon J-P. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006, 368:843-54. 10.1016/S0140-6736(06)69121-6, 16950362.
40. Budach W, Her T, Budach V, Belka C, Dietz K. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer 2006, 6:28. 10.1186/1471-2407-6-28, 1379652, 16448551.
41. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 2000, 355:949-955.
42. Pignon J-P, le Maitre A, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomized trials and 17,346 patients. Radiother Oncol 2009, 92:4-14. 10.1016/j.radonc.2009.04.014, 19446902.
43. Budach V, Stuschke M, Budach W, Baumann M, Geismar D, Grabenbauer G, Lammert I, Jahnke K, Stueben G, Herrmann T, Bamberg M, Wust P, Hinkelbein W, Wernecke K-D. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the Radiotherapy Cooperative Clinical Trials Group of the German Cancer Society 95-06 prospective randomized trial. J Clin Oncol 2005, 23:1125-1135. 10.1200/JCO.2005.07.010, 15718308.
44. Jeremic B, Milicic B, Dagovic A, Vaskovic Z, Tadic L. Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck. J Clin Oncol 2004, 22:3540-3548. 10.1200/JCO.2004.10.076, 15337803.
45. Huguenin P, Beer KT, Allal A, Rufibach K, Friedli C, Davis JB, Pestalozzi B, Schmid S, Thöni A, Ozsahin M, Bernier J, Töpfer M, Kann R, Meier UR, Thum P, Sabine B, Notter M, Lombriser N, Glanzmann C. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. J Clin Oncol 2004, 22:4665-4673. 10.1200/JCO.2004.12.193, 15534360.
46. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006, 354:567-578. 10.1056/NEJMoa053422, 16467544.
47. Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, Raben D, Baselga J, Spencer SA, Zhu J, Youssoufian H, Rowinsky EK, Ang KK. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 2010, 11:21-28. 10.1016/S1470-2045(09)70311-0, 19897418.
48. Haddad RI, Shin DM. Recent advances in head and neck cancer. N Engl J Med 2008, 359:1143-1154. 10.1056/NEJMra0707975, 18784104.